百花医药：拟使用19.10亿元资本公积金弥补亏损

Core Viewpoint - Baihua Pharmaceutical (600721.SH) announced plans to use a total of 1.91 billion yuan from its surplus reserve and capital reserve to cover losses, primarily due to goodwill impairment from a previous major asset restructuring [1] Group 1: Financial Actions - The company will hold a board and shareholder meeting on October 27, 2025, to review the proposal for using the surplus and capital reserves [1] - The total amount allocated for loss compensation is 1.91 billion yuan [1] Group 2: Reasons for Losses - The negative retained earnings of the parent company are mainly attributed to the impact of goodwill impairment from the previous major asset restructuring [1] Group 3: Creditor Notification - The company has notified creditors that they can request debt repayment or corresponding guarantees within 30 days from the receipt of the notice or 45 days from the announcement disclosure [1]